Method of modulating ribonucleotide reductase
US11439623B2 · kind B2 · utility
0Cited by
12References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 4, 2018 |
| Grant date | Sep 13, 2022 |
| Priority date | — |
| Expiry date | Jul 18, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of modulating ribonucleotide reductase activity in a neoplastic cell includes administering to the cell an amount of a triazole or an oxadiazole ribonucleotide reductase modulator (RRmod), the amount being effective to inhibit neoplastic cell growth.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.